Remifentanil

Addiction, Abuse, and Misuse

Addiction, Abuse, and Misuse

• ULTIVA exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing ULTIVA

Life-Threatening Respiratory Depression

• Opioids can cause sleep-related breathing disorders including central sleep apnea (CSA) and sleep-related hypoxemia. Opioid use increases the risk of CSA in a dose-dependent fashion. In patients who present with CSA, consider decreasing the opioid dosage using best practices for opioid taper.

Patient Counseling Information

• ULYIVA

Package Inserts

Remifentanil